The school nurse completes an assessment of a 6-year-old child to determine the services this child will need in the classroom
The child needs respiratory support with oxygen. The child requires enteral-tube feedings and intravenous medications during the school day. With these needs,the school nurse evaluates the child to be
1. developmentally delayed.
2. mentally retarded.
3. socially withdrawn.
4. medically fragile.
Answer:4
Rationale: A child who is dependent on medical devices for survival or prevention of further disability is medically fragile. There is no behavioral evidence to support a finding that the child is developmentally delayed,mentally retarded,or socially withdrawn. A child who is medically fragile is not necessarily developmentally delayed,mentally retarded,or socially withdrawn.
You might also like to view...
You note that your patient has diaphoresis, generalized hyperthermia, and very soft and silklike skin. In the absence of a fever or recent exercise, you determine that the most likely cause of these findings is
a. hypothyroidism. c. hyperthyroidism. b. anxiety. d. peripheral vascular disease.
A child with leukemia is prescribed to receive ondansetron hydrochloride (Zofran) 0.15 mg/kg intravenously prior to receiving the first dose of chemotherapy. The child weighs 55 lb
How many milligrams of the medication should the nurse provide to the child? (Numeric value only. Calculate to the nearest tenth decimal point.)
How have recent changes in health care delivery affected practice settings for medi-cal-surgical nurses?
A. Third-party payment systems have restricted the delivery of medical-surgical nursing services to acute care hospitals. B. Managed care organizations prefer less expensive care delivered by unlicensed personnel. C. Medical-surgical nursing is practiced in community centers and long-term care facilities. D. The delivery of medical-surgical nursing practice is now limited to adults only.
Select the statement that describes the major site where antiviral action is blocked by the protease inhibitors.
A. The protease inhibitors block the uncoating process of the human immunodeficiency virus by binding to protease. B. The protease inhibitors inhibit the late protein synthesis and processing of the human immunodeficiency virus. C. The protease inhibitors block the ability of the human immunodeficiency virus from attaching and entering the cell membrane. D. The protease inhibitors block the nucleic acid synthesis of the human immunodeficiency virus.